Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort. (April 2023)
- Record Type:
- Journal Article
- Title:
- Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort. (April 2023)
- Main Title:
- Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort
- Authors:
- Escrihuela-Vidal, Francesc
Kaasch, Achim J.
Von Cube, Maja
Rieg, Siegbert
Kern, Winfried V.
Seifert, Harald
Song, Kyoung-Ho
Liao, Chun-Hsing
Tilley, Robert
Gott, Hannah
Scarborough, Matt
Gordon, Claire
Llewelyn, Martin J.
Kuehl, Richard
Morata, Laura
Soriano, Alex
Edgeworth, Jonathan
De Gopegui, Enrique Ruiz
Nsutebu, Emmanuel
Cisneros, José Miguel
Fowler, Vance G.
Thwaites, Guy
López-Contreras, Joaquín
Barlow, Gavin
Ternavasio-De La Vega, Hugo Guillermo
Rodríguez-Baño, Jesús
López-Cortés, Luis Eduardo - Abstract:
- Abstract: Objectives: To analyse the adherence and impact of quality-of-care indicators (QCIs) in the management of Staphylococcus aureus bloodstream infection in a prospective and multicentre cohort. Methods: Analysis of the prospective, multicentre international S. Aureus Collaboration cohort of S. Aureus bloodstream infection cases observed between January 2013 and April 2015. Multivariable analysis was performed to evaluate the impact of adherence to QCIs on 90-day mortality. Results: A total of 1784 cases were included. Overall, 90-day mortality was 29.9% and mean follow-up period was 118 days. Adherence was 67% ( n = 1180/1762) for follow-up blood cultures, 31% ( n = 416/1342) for early focus control, 77.6% ( n = 546/704) for performance of echocardiography, 75.5% ( n = 1348/1784) for adequacy of targeted antimicrobial therapy, 88.6% ( n = 851/960) for adequacy of treatment duration in non-complicated bloodstream infections and 61.2% ( n = 366/598) in complicated bloodstream infections. Full bundle adherence was 18.4% ( n = 328/1784). After controlling for immortal time bias and potential confounders, focus control (adjusted hazard ratio = 0.76; 95% CI, 0.59–0.99; p 0.038) and adequate targeted antimicrobial therapy (adjusted hazard ratio = 0.75; 95% CI, 0.61–0.91; p 0.004) were associated with low 90-day mortality. Discussion: Adherence to QCIs in S. Aureus bloodstream infection did not reach expected rates. Apart from the benefits of application as a bundle,Abstract: Objectives: To analyse the adherence and impact of quality-of-care indicators (QCIs) in the management of Staphylococcus aureus bloodstream infection in a prospective and multicentre cohort. Methods: Analysis of the prospective, multicentre international S. Aureus Collaboration cohort of S. Aureus bloodstream infection cases observed between January 2013 and April 2015. Multivariable analysis was performed to evaluate the impact of adherence to QCIs on 90-day mortality. Results: A total of 1784 cases were included. Overall, 90-day mortality was 29.9% and mean follow-up period was 118 days. Adherence was 67% ( n = 1180/1762) for follow-up blood cultures, 31% ( n = 416/1342) for early focus control, 77.6% ( n = 546/704) for performance of echocardiography, 75.5% ( n = 1348/1784) for adequacy of targeted antimicrobial therapy, 88.6% ( n = 851/960) for adequacy of treatment duration in non-complicated bloodstream infections and 61.2% ( n = 366/598) in complicated bloodstream infections. Full bundle adherence was 18.4% ( n = 328/1784). After controlling for immortal time bias and potential confounders, focus control (adjusted hazard ratio = 0.76; 95% CI, 0.59–0.99; p 0.038) and adequate targeted antimicrobial therapy (adjusted hazard ratio = 0.75; 95% CI, 0.61–0.91; p 0.004) were associated with low 90-day mortality. Discussion: Adherence to QCIs in S. Aureus bloodstream infection did not reach expected rates. Apart from the benefits of application as a bundle, focus control and adequate targeted therapy were independently associated with low mortality. … (more)
- Is Part Of:
- Clinical microbiology and infection. Volume 29:Number 4(2023)
- Journal:
- Clinical microbiology and infection
- Issue:
- Volume 29:Number 4(2023)
- Issue Display:
- Volume 29, Issue 4 (2023)
- Year:
- 2023
- Volume:
- 29
- Issue:
- 4
- Issue Sort Value:
- 2023-0029-0004-0000
- Page Start:
- 498
- Page End:
- 505
- Publication Date:
- 2023-04
- Subjects:
- Management -- Mortality -- Quality of care indicators -- Staphylococcus aureus
Medical microbiology -- Periodicals
Diagnostic microbiology -- Periodicals
Communicable diseases -- Periodicals
Infection -- Periodicals
616.01 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1469-0691 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.cmi.2022.10.019 ↗
- Languages:
- English
- ISSNs:
- 1198-743X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.305520
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26856.xml